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Abstract: Patellofemoral pain (PFP) is a common atraumatic knee pathology in runners, with a com- 13 
plex multifactorial aetiology influenced by sex differences. This retrospective case-control study 14 
therefore aimed to evaluate lower limb kinetics and kinematics in symptomatic and control male 15 
and female runners using musculoskeletal simulation. Lower extremity biomechanics were as- 16 
sessed in 40 runners with PFP (15 females & 25 males) and 40 controls (15 females & 25 males), 17 
whilst running at a self-selected velocity. Lower extremity biomechanics were explored using a 18 
musculoskeletal simulation approach. Four between group comparisons 1. Overall PFP vs. Control, 19 
2. Male PFP vs. Male Control, 3. Female PFP vs. Female Control and 4. Male PFP vs. Female PFP 20 
were undertaken using linear mixed models. The overall (stress per mile: PFP=1047.49 & Con- 21 
trol=812.93) and female (peak stress: PFP=13.07KPa/BW & Control=10.82KPa/BW) comparisons 22 
showed increased patellofemoral joint stress indices in PFP runners. A significantly lower strike 23 
index was also shown in PFP runners in the overall (PFP=17.75% & Control=33.57%) and female 24 
analyses (PFP=15.49% & Control=40.20%), which revealed a midfoot strike in control, and a rearfoot 25 
pattern in PFP runners. Peak rearfoot eversion and contralateral pelvic drop range of motion (ROM) 26 
were shown to be greater in PFP runners in the overall (eversion: PFP=-8.15° & Control=-15.09°/ 27 
pelvic drop ROM: PFP=3.64° & Control=1.88°), male (eversion: PFP=-8.05° & Control=-14.69°/ pelvic 28 
drop ROM: PFP=3.16° & Control=1.77°) and female (eversion: PFP=8.28° & Control=-15.75°/ pelvic 29 
drop ROM: PFP=3.64° & Control=1.88°) PFP runners, whilst female PFP runners (11.30°) exhibited 30 
a significantly larger peak hip adduction compared to PFP males (7.62°). The findings from this 31 
investigation identify biomechanical differences between control and PFP runners as well as 32 
demonstrating distinctions in PFP presentation for many parameters between sexes. Highlighting 33 
potential risk factors for PFP that may be addressed through focused intervention modalities and 34 
also the need where appropriate, for sex specific targeted treatment approaches. 35 
Keywords: Patellofemoral pain; Running; Musculoskeletal simulation; Anterior knee pain; Kine- 36 
matics. 37 
 38 
1. Introduction 39 
Both recreational and competitive distance running is associated with a plethora of phys- 40 
iological benefits [1]. However, despite the physical improvements mediated by running, 41 
it is also linked with a very high rate of overuse injuries [2, 3]. Patellofemoral pain (PFP) 42 
is a common atraumatic knee pathology that typically manifests as retropatellar or peri- 43 
patellar pain and inflammation, aggravated by activities that frequently load the joint [4]. 44 
PFP has an incidence rate as high as 21% in runners [5], with a much larger prevalence in 45 
females [6]. The long-term prognosis is poor, with between 71-91% of patients experienc- 46 
ing symptoms 20 years following diagnosis [7]. PFP symptoms may later present with 47 
radiographic evidence of osteoarthritis at this joint [8], and pain symptoms force many to 48 
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reduce or even end their running training [9]; causing many to develop associated psy- 49 
chological disorders [10]. 50 
The lack of treatment efficacy is attributed to the multifactorial nature and complex 51 
aetiology of PFP, which makes the identification of modifiable risk factors problematic 52 
[11]. Given the high incidence of PFP in runners [5]; an enhanced comprehension of the 53 
parameters linked to PFP aetiology and its distinct incidence in differing populations is 54 
essential to prevent symptoms and improve management. Recent prospective pooled sys- 55 
tematic review and meta-analytic analyses have shown physiological indices of quadri- 56 
ceps weakness and hip abduction strength to be risk factors for PFP in military and ado- 57 
lescent populations, although no identifiable risk factors were evident in runners [12].  58 
There are a lack of prospective investigations exploring the biomechanical mecha- 59 
nisms linked to the aetiology of PFP in runners [4]. Noehren et al., [13], showed that female 60 
runners were at an increased risk of developing PFP in the presence of a statistically 61 
greater maximum hip adduction angle. Furthermore, in relation to asymptomatic con- 62 
trols, Fox et al., [14] showed that PFP runners exhibited increased peak hip adduction, hip 63 
transverse plane range of motion (ROM), peak knee flexion, peak knee abduction and 64 
peak dorsiflexion. Noehren et al., [15, 16] revealed that in female PFP runners, increased 65 
hip adduction, hip internal rotation and tibial internal rotation was evident compared to 66 
controls. Esculier et al., [17] showed that runners with PFP exhibited higher hip adduction 67 
at toe-off, lower hip adduction ROM during late-stance and longer of soleus activation. 68 
Conversely Dierks et al., [18] showed that runners with PFP demonstrated reduced peak 69 
knee flexion, peak hip adduction, eversion ROM, peak knee flexion velocity, peak hip ad- 70 
duction velocity, and peak hip internal rotation velocity compared with controls. Finally, 71 
Willson & Davis, [19] revealed that females with PFP demonstrated greater hip adduction 72 
and contralateral pelvic drop in relation to asymptomatic runners. Neal et al., [12] pro- 73 
posed that these kinematic variations contribute to the development and persistence of 74 
PFP by way of increased patellofemoral joint stress, although patellofemoral joint loading 75 
has not yet been explored in runners with PFP in relation to asymptomatic controls. 76 
Although previous analyses have explored running biomechanics in those with PFP 77 
compared to healthy controls, the majority utilized only female runners or a mixed sex 78 
sample, without considering of the effects of sex. As such the effects of sex on running 79 
biomechanics in those with PFP is poorly understood [12]. Willy et al., [20] compared run- 80 
ning biomechanics in male and female runners with PFP and showed that females exhib- 81 
ited greater peak hip adduction compared to both males with PFP and male controls, 82 
whereas males with PFP ran with a greater peak knee adduction compared to sympto- 83 
matic females and male controls. A drawback of this investigation was the lack of a female 84 
control group and Neal et al., [4] undertook the only investigation examine male and fe- 85 
male runners with PFP in relation to asymptomatic controls of both sexes. Mixed-sex com- 86 
parisons showed that PFP runners exhibited greater peak hip adduction compared to con- 87 
trols. Females with PFP demonstrated significantly greater peak hip adduction compared 88 
to controls but there were no differences between males with PFP and male controls.  89 
Previous analyses concerning the biomechanical differences between runners with 90 
PFP and asymptomatic controls have examined only joint kinematics, ground reaction 91 
forces and surface electromyography. Significant advances have been made in musculo- 92 
skeletal simulation models [21], leading to the development of bespoke software, allowing 93 
skeletal muscle forces to be simulated during movement and utilized as inputs to calculate 94 
lower extremity joint reaction forces [22]. Such approaches have been used extensively in 95 
running, but only one study has explored differences in those with PFP and healthy con- 96 
trols. Besier et al., [23] showed that medial gastrocnemius forces were significantly larger 97 
in PFP runners, which they speculated may cause greater joint contact loads in compari- 98 
son to pain-free runners, although joint loading indices were not undertaken in this inves- 99 
tigation. With the high incidence of PFP in runners [5], allied to a poor long-term progno- 100 
sis [7], further investigation is warranted to better understand the biomechanical variables 101 
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associated with PFP and the increased incidence of this pathology in female runners, to 102 
enhance the quality of future evidence based preventative strategies for both sexes. 103 
This investigation aimed via a retrospective case-control study design, to firstly eval- 104 
uate running biomechanics in a pooled sex sample of runners with and without PFP using 105 
a musculoskeletal simulation-based approach. Secondly using the same experimental ap- 106 
proach, this investigation seeks to explore differences between PFP and asymptomatic 107 
controls, when these cohorts were divided into subset comparisons of males and females 108 
with and without PFP, to investigate distinctions in PFP presentation between the sexes. 109 
2. Materials and Methods 110 
2.1 Participants 111 
The University of Central Lancashire granted ethical approval for this study (STEMH 112 
424), and all participants provided written informed consent prior to participation in ac- 113 
cordance with the Declaration of Helsinki. Runners with and without PFP were recruited 114 
from local sports physiotherapy clinics and running clubs/ teams. An a priori sample size 115 
calculation for independent group comparisons between sexes was undertaken, using the 116 
formulae outlined by Rosner, [24]. The peak patellofemoral joint stress was adopted as the 117 
primary dependent variable. Using data from our previous work, (males with PFP 13.10 118 
±3.05 megapascals (MPa) [25], male controls 10.80 MPa ±3.04 [26], females with PFP 10.60 119 
MPa ±1.20 [27], and female controls 9.27 MPa ±1.36 [28]) it was determined that to achieve 120 
α = 5% and β = 0.80, 15 female and 25 male runners were required in both the control and 121 
PFP groups.  122 
Specific diagnosis of PFP was made in accordance with previous guidelines [29], it 123 
was also required that runners had experienced patellofemoral symptoms for a minimum 124 
of 3 months that were exacerbated by running or other activities. Participants with any 125 
other knee/ lower limb pathology or previous lower limb surgery were excluded. For in- 126 
clusion in the control group, it was necessary for runners to be free of running-related 127 
injury for at least three months and have no prior history of anterior knee pain. Both 128 
groups were commonly; participants of either sex, running at least of 10 km per week and 129 
aged between 18-45 years [4]. 130 
2.2 Procedures 131 
Participants presented to the Biomechanics Laboratory at the University of Central Lan- 132 
cashire. In runners who experienced bilateral PFP, the limb that exhibited the greater 133 
symptoms was included [4]. For the control participants, the dominant limb (defined as 134 
the limb that would be used to kick a football) was utilized [20]. Participants in the PFP 135 
group completed the Knee Osteoarthritis Outcome Score Patellofemoral subscale (KOOS- 136 
PF) This scale is scored from 0 to 100, with 100 representing no disability and 0 represent- 137 
ing maximum disability [30]. 138 
Participants ran across the biomechanics laboratory, striking an embedded piezoe- 139 
lectric force platform (Kistler Instruments Ltd., Winterthur, Switzerland) which sampled 140 
at 1000 Hz, with their appropriate foot. Participants were required to run in their usual 141 
running shoes and at their own typical/ self-selected running speed. The stance phase was 142 
delineated as the duration over which 20 N or greater of vertical ground reaction force 143 
(GRF) was applied to the force platform [31]. Runners completed five successful trials, 144 
with a successful trial being defined as one where the foot made full contact with the force 145 
platform and with no evidence of gait modifications due to the experimental conditions. 146 
Kinematic and GRF data were synchronously collected. Kinematic data were captured at 147 
250 Hz via an eight-camera motion analysis system (Qualisys Medical AB, Goteburg, Swe- 148 
den). Dynamic calibration of the motion capture system was performed before each data 149 
collection session. 150 
Body segments were modelled in 6 degrees of freedom using the calibrated anatom- 151 
ical systems technique [32]. To define the anatomical frames of the thorax, pelvis, thighs, 152 
shanks and feet, retroreflective markers were placed at the seventh cervical vertebrae (C7), 153 
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twelfth thoracic vertebrae (T12) and xiphoid process landmarks, and also positioned bi- 154 
laterally onto the acromion process, iliac crest, anterior superior iliac spine (ASIS), poste- 155 
rior super iliac spine (PSIS), medial and lateral malleoli, medial and lateral femoral epi- 156 
condyles, greater trochanter, calcaneus, first metatarsal and fifth metatarsal (Figure 1a). 157 
Intra-rater reliability for the researcher responsible for positioning of the aforementioned 158 
anatomical markers has been shown to be excellent [33]. The centre’s of the ankle and knee 159 
joints were delineated as the mid-point between the malleoli and femoral epicondyle 160 
markers [34, 35]. The hip joint centre was determined using a regression equation that 161 
uses the positions of the ASIS markers [36]. Carbon-fibre tracking clusters comprising of 162 
four non-linear retroreflective markers were positioned onto the thigh and shank seg- 163 
ments. In addition, the foot segments were tracked via the calcaneus, first metatarsal and 164 
fifth metatarsal, the pelvic segment was tracked using the PSIS and ASIS markers and the 165 
thorax segment was tracked using the T12, C7 and xiphoid markers. Static calibration tri- 166 
als were obtained allowing for the anatomical markers to be referenced in relation to the 167 
tracking markers/clusters. The Z (transverse) axis was oriented vertically from the distal 168 
segment end to the proximal segment end. The Y (coronal) axis was oriented in the seg- 169 
ment from posterior to anterior. Finally, the X (sagittal) axis orientation was determined 170 
using the right-hand rule and was oriented from medial to lateral (Figure 1b).  171 
@@@FIGURE 1 NEAR HERE@@@ 172 
2.3 Processing 173 
Dynamic trials were digitised using Qualisys Track Manager (Qualisys Medical AB, Gote- 174 
burg, Sweden) in order to identify anatomical and tracking markers, then exported as C3D 175 
files to Visual 3D (C-Motion, Germantown, MD, USA). All data were linearly normalized 176 
to 100% of the stance phase. GRF data and marker trajectories were smoothed with cut- 177 
off frequencies of 50 Hz at 12 Hz respectively, using a low-pass Butterworth 4th order zero 178 
lag filter. Lower extremity kinematics were quantified using an XYZ cardan sequence of 179 
rotations (where X is flexion-extension; Y is ab-adduction and is Z is internal-external ro- 180 
tation). Tibial internal rotation kinematics were also calculated in accordance with Eslami 181 
et al., [37]. Finally, in order to quantify contralateral pelvic drop, the coronal plane angle 182 
of the pelvic segment was quantified with respect to the laboratory. Three-dimensional 183 
kinematic measures were extracted for statistical analysis were 1) angle at footstrike, 2) 184 
peak angle and 3) range of motion (representing the angular displacement from footstrike 185 
to peak angle). Running speed was also quantified withing Visual 3D using the linear 186 
velocity of the model centre of mass in the anterior direction. 187 
In accordance with the protocol of Addison and Lieberman, [38], an impulse-mo- 188 
mentum modelling approach was utilized to calculate effective mass as a percentage of 189 
bodyweight (% BW), which was quantified in accordance with the below equation: 190 
 191 
Effective mass = vertical GRF integral / (Δ foot vertical velocity + gravity * Δ time) 192 
 193 
The impact peak was defined in the maximal and traditional running shoes as the first 194 
peak in vertical GRF. The time to impact peak (Δ time) was quantified as the duration 195 
from footstrike to impact peak. For runners who lacked an impact peak, in accordance 196 
with Sinclair et al., [39] we calculated based on a mean of the other runners the relative 197 
position of the impact peak as a percentage of the stance phase and positioned the impact 198 
peak here in those who did not exhibit a disenable peak in the vertical GRF time-curve. 199 
The vertical GRF integral during the period of the impact peak was calculated using a 200 
trapezoidal function. The change in foot vertical velocity (Δ foot vertical velocity) was 201 
determined as the change in vertical foot velocity between the instances of footstrike and 202 
the impact peak [40]. The velocity of the foot was quantified using the centre of mass of 203 
the foot segment in the vertical direction, within Visual 3D [39]. 204 
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The loading rate expressed as bodyweight per second (BW/s) was also extracted by 205 
obtaining the peak increase in vertical GRF between adjacent data points using the first 206 
derivative function within Visual 3D. Furthermore, the GRF impulse expressed as body- 207 
weight per millisecond (BW·ms) during the stance phase in all three anatomical directions 208 
was calculated using a trapezoidal function. The strike index (%) was calculated as the 209 
position of the centre of pressure location at footstrike, relative to the total length of the 210 
foot [41] (Figure 2a-c). A strike index of 0–33.3 % denotes a rearfoot, 33.4–66.6% a midfoot 211 
and 66.7–100% a forefoot strike pattern. Finally, vertical limb stiffness during running was 212 
quantified using a mathematical spring-mass model [42]. Vertical limb stiffness expressed 213 
as bodyweight per metre (BW/m) was calculated from the ratio of the peak vertical GRF 214 
normalized to bodyweight (BW) to the maximum vertical compression of the leg spring 215 
which was calculated as the change in limb length from footstrike to minimum length 216 
during the stance phase [43]. Limb length (m) was quantified as the vertical height of the 217 
proximal end of the thigh segment within Visual 3D. 218 
@@@FIGURE 2 NEAR HERE@@@ 219 
Following this, data during the stance phase were exported from Visual 3D into 220 
OpenSim 3.3 software (Simtk.org). A validated musculoskeletal model was used to pro- 221 
cess the biomechanical data, which was scaled to account for the anthropometrics of each 222 
runner. The model with 12 segments, 19 degrees of freedom and 92 musculotendon actu- 223 
ators [44] was used to estimate lower extremity muscle and joint forces. A residual reduc- 224 
tion algorithm [22] was firstly used to resolve dynamic inconsistency between the meas- 225 
ured GRF’s and the model's kinematics and muscle kinetics were then quantified using 226 
static optimization in accordance with Steele et al. [45]. 227 
From the above static optimization processes, the peak model muscle forces during 228 
the stance phase were extracted after being normalized to bodyweight (BW). Furthermore, 229 
the impulses (BW·ms) during the stance phases for the aforementioned muscles were also 230 
extracted using a trapezoidal function. In addition, the biceps femoris long-head, biceps 231 
femoris short-head, semitendinosus and semimembranosus muscle forces were summed 232 
to create the total hamstring muscle force and the rectus femoris, vastus lateralis, vastus 233 
medialis and vastus intermedius forces were also summed to create the total quadriceps 234 
muscle force. The peak total hamstring and quadriceps forces as well as their impulses 235 
during the stance phase were also extracted. In accordance with Besier et al., [23], the mean 236 
(%) contributions of each of the individual hamstring and quadriceps muscles to the total 237 
hamstring and total quadriceps forces during the stance phase was quantified. Finally, the 238 
mean co-contraction ratio was calculated by dividing the total hamstring force impulse by 239 
the total quadriceps impulse and peak co-contraction ratio by dividing the total hamstring 240 
force at the instance of peak patellofemoral force by the total quadriceps force at the same 241 
time point.  242 
As muscle forces are the main determinant of joint compressive forces [46], following 243 
the static optimization process the peak compressive patellofemoral joint force (BW) was 244 
calculated via the joint reaction analyses function using the muscle forces generated from 245 
the static optimization process as inputs [22]. Furthermore, peak patellofemoral stress ex- 246 
pressed as kilopascals per bodyweight (KPa/BW) was quantified by dividing the patello- 247 
femoral force by the joint contact area. Patellofemoral contact areas were obtained by fit- 248 
ting a polynomial curve to the sex specific data of Besier et al. [47], who estimated patel- 249 
lofemoral contact areas as a function of the knee flexion angle using magnetic resonance 250 
imaging. In addition, peak patellofemoral force (BW·ms) and stress (expressed as kilopas- 251 
cals per bodyweight per millisecond - KPa/BW·ms) impulses during the stance phase were 252 
extracted, also using a trapezoidal function. Finally, patellofemoral force/ stress load rates 253 
(BW/s and KPa/BW/s i.e. kilopascals per bodyweight per second) were extracted by ob- 254 
taining the maximum increase in force/stress between adjacent data points using a first 255 
derivative function. 256 
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Further to the above, the patellofemoral force (BW) and patellofemoral stress 257 
(KPa/BW) experienced per mile were also quantified to explore the effect of step length 258 
on loading at this joint [48]. The number of steps needed to complete 1 mile was quantified 259 
using the step length (m), which was determined by taking the difference in the horizontal 260 
position of the foot centre of mass between the right and left limbs at foot strike from each 261 
running trial [49]. To obtain the force/ stress experienced per mile, impulse values for 262 
these measures outlined above, were multiplied by the number of steps required to run a 263 
mile.  264 
2.4 Statistical analyses 265 
For each outcome variable and group, means and standard deviations (SD) were calcu- 266 
lated. Differences between four pairs of group comparisons were undertaken. 1. Overall 267 
PFP vs. Control groups were contrasted which involved all PFP runners compared against 268 
all of the asymptomatic runners. Following this subset analyses of 2. Male PFP vs. Male 269 
Control, 3. Female PFP vs. Female Control and 4. Male PFP vs. Female PFP were under- 270 
taken. To compare participant characteristics (age, mass, stature, BMI, running speed, step 271 
length, mean weekly running volume), linear mixed models with group modelled as a 272 
fixed factor and random intercepts by participants were adopted to compare pairs 1-4. 273 
Symptom duration and KOOS-PF were comparable in pair 4 only.  274 
To compare biomechanical outcomes across the four pairs of groups, the same ap- 275 
proach was adopted only adjusting for running speed which was modelled as continuous 276 
fixed covariate. In addition, for group comparisons from pairs 1-3 outlined above, binary 277 
logistic regression analysis was conducted with the biomechanical parameters as the pre- 278 
dictor variables and classification into either the PFP group as the outcome variable. Fi- 279 
nally, two-way Pearson chi-square (X2) tests of independence with probability values cal- 280 
culated by Monte Carlo simulation, were used to assess differences in the distribution of 281 
the three-foot strike patterns between the pairs. Only, parameters identified to be signifi- 282 
cantly different between control and PFP groups using linear mixed model analyses, were 283 
considered for the regression analyses. All statistical analyses were conducted using SPSS 284 
v27 (IBM, SPSS). For linear mixed models, the mean difference (b), t-value and 95% confi- 285 
dence intervals of the difference are presented. For binary logistic regression analyses, the 286 
odds ratio (OR) and 95% confidence intervals of the odds ratio are presented. Statistical 287 
significance for all analyses was accepted at the P<0.05 level. In the interests of conciseness 288 
and clarity only variables that presented with statistical significance are presented in the 289 
results section. 290 
3. Results 291 
3.1 Participant characteristics 292 
Comparisons between all groups for (age, BMI, running speed, mean weekly running vol- 293 
ume, symptom duration and KOOS-PF) were non-significant (p=0.12-0.97). However, 294 
mass (b = 15.98, (95% CI = 7.25 – 24.69), t = 3.71, p<0.001) and stature (b = 0.11, (95% CI = 295 
0.08 – 0.15), t = 5.68, p<0.001) were significantly greater in symptomatic males compared 296 
to females with PFP. Furthermore, step length was shown to be significantly greater in the 297 
control group compared to overall PFP (b = 0.27, (95% CI = 0.14 – 0.40), t = 4.023, p<0.001) 298 
and in male controls in relation to male PFP runners (b = 0.15, (95% CI = 0.07 – 0.22), t = 299 
4.067, p<0.001) (Table 1).  300 
@@@TABLE 1 NEAR HERE@@@ 301 
3.2 Overall PFP vs. Control 302 
Knee flexion at footstrike, knee external rotation at footstrike, peak knee flexion, knee cor- 303 
onal plane ROM, knee transverse plane ROM and ankle transverse plane ROM were sig- 304 
nificantly larger in the control group. Hip external rotation at footstrike, hip sagittal plane 305 
ROM, knee abduction at footstrike, ankle eversion at footstrike, ankle external rotation at 306 
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footstrike, peak ankle eversion and pelvic ROM were significantly larger in the PFP group 307 
(Table 2). 308 
@@@TABLE 2 NEAR HERE@@@ 309 
In addition, the strike index was significantly greater in the control group. The patello- 310 
femoral force per mile and patellofemoral stress per mile were significantly larger in the 311 
PFP group (Table 3). 312 
@@@TABLE 3 NEAR HERE@@@ 313 
Peak adductor longus force, flexor digitorum longus impulse, flexor hallucis longus im- 314 
pulse, gluteus minimus impulse, peroneus tertius impulse, semitendinosus impulse, peak 315 
semitendinosus force, soleus impulse, semitendinosus %, vastus intermedius %, vastus 316 
lateralis %, vastus medialis and mean co-contraction ratio were significantly greater in the 317 
control group. were significantly larger in the control group. The peak extensor hallucis 318 
longus force, peak lateral gastrocnemius force, rectus femoris impulse, peak semimem- 319 
branosus force, biceps femoris short head % and rectus femoris % were significantly 320 
greater in the PFP group (Table 4). 321 
@@@TABLE 4 NEAR HERE@@@ 322 
The control group was comprised of 25 rearfoot strikers, 11 midfoot strike runners and 4 323 
forefoot strikers, whereas the PFP group had 37 rearfoot strike runners, 2 midfoot strikers 324 
and 1 forefoot runner. The chi-squared test was significant (X2 (2) = 10.35, P=0.006) with 325 
statistically more rearfoot runners in the PFP group and more mid and forefoot strikers in 326 
the control group. 327 
 328 
3.3 Male PFP vs. Male Control 329 
The ankle transverse plane ROM was significantly greater in the control group. The ankle 330 
eversion at footstrike, ankle internal rotation at footstrike, peak ankle eversion, and pelvic 331 
ROM were significantly greater in the PFP group (Table 5).  332 
@@@TABLE 5 NEAR HERE@@@ 333 
In addition, adductor magnus impulse, gluteus minimus impulse, peroneus brevis im- 334 
pulse, peak peroneus brevis force, semitendinosus impulse, peak semitendinosus force, 335 
peak soleus force, semitendinosus %, vastus intermedius %, vastus lateralis % and vastus 336 
medialis % were significantly greater in the control group. Rectus femoris % was however 337 
significantly greater in the PFP group (Table 6). 338 
@@@TABLE 6 NEAR HERE@@@ 339 
The control group was comprised of 19 rearfoot strikers, 4 midfoot strike runners and 2 340 
forefoot strikers, whereas the male PFP group had 22 rearfoot strike runners, 2 midfoot 341 
strikers and 1 forefoot runner. The chi-squared test was non-significant (X2 (2) = 1.56, 342 
P=0.458). 343 
 344 
3.4 Female PFP vs. Female Control 345 
Knee external rotation at footstrike and knee transverse plane ROM were significantly 346 
greater in the control group. Knee abduction at footstrike, ankle dorsiflexion at footstrike, 347 
ankle eversion at footstrike, ankle external rotation at footstrike, peak ankle dorsiflexion, 348 
peak ankle eversion and pelvic ROM were significantly larger in the PFP group (Table 7). 349 
@@@TABLE 7 NEAR HERE@@@ 350 
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In addition, the strike index was significantly greater in the control group. The vertical 351 
GRF impulse, patellofemoral force impulse, peak patellofemoral force, peak patellofemo- 352 
ral stress, patellofemoral stress loading rate, patellofemoral stress impulse and patello- 353 
femoral stress per mile were significantly larger in the PFP group (Table 8). 354 
@@@TABLE 8 NEAR HERE@@@ 355 
Peak adductor longus force Semitendinosus %, vastus intermedius %, vastus lateralis % 356 
and vastus medialis % were significantly greater in the control group. Peak biceps femoris 357 
short head force, peak extensor hallucis longus force, peak lateral gastrocnemius force, 358 
peak medial gastrocnemius force, peak peroneus longus force, psoas impulse, rectus fem- 359 
oris impulse, peak semimembranosus force, total quadriceps impulse, peak total quadri- 360 
ceps force, peak vastus intermedius force, vastus intermedius impulse, peak vastus medi- 361 
alis force, vastus medialis impulse and rectus femoris % were significantly greater in the 362 
PFP group (Table 9). 363 
@@@TABLE 9 NEAR HERE@@@ 364 
The control group was comprised of 7 rearfoot strikers, 6 midfoot strike runners and 2 365 
forefoot strikers, whereas the female PFP group had 15 rearfoot strike runners. The chi- 366 
squared test was significant (X2 (2) = 11.05, P=0.004) with statistically more rearfoot runners 367 
in the female PFP group and more mid and forefoot strikers in the control group. 368 
 369 
3.5 Male PFP vs. Female PFP 370 
Hip flexion at footstrike, peak hip adduction, knee flexion at footstrike and peak knee 371 
flexion were significantly larger in the female PFP group. Knee transverse plane ROM was 372 
significantly greater in the male PFP group (Table 10). 373 
@@@TABLE 10 NEAR HERE@@@ 374 
The loading rate was significantly larger in the female PFP group (Table 11). 375 
@@@TABLE 11 NEAR HERE@@@ 376 
Biceps femoris long head impulse, peak biceps femoris short head force, gluteus maximus 377 
impulse, peak gluteus maximus force, gluteus medius impulse, peak gluteus medius 378 
force, gluteus minimus impulse, peak gluteus minimus force, peak gracillis force, peak 379 
iliacus force, peak sartorius force, semimembranosus impulse, peak semimembranosus 380 
force, semitendinosus impulse, peak semitendinosus force, tensor fasciae latae impulse, 381 
peak tensor fasciae latae force, tibialis anterior impulse, total hamstring impulse, peak to- 382 
tal hamstring force vastus intermedius %, vastus lateralis %, mean co-contraction ratio 383 
and peak co-contraction ratio were significantly greater in the female PFP group. Extensor 384 
digitorum longus impulse, flexor digitorum longus impulse, rectus femoris impulse and 385 
rectus femoris % were significantly greater in the male PFP group (Table 12). 386 
@@@TABLE 12 NEAR HERE@@@ 387 
The male PFP group was comprised of 2 rearfoot strikers, 1 midfoot strike runners and 1 388 
forefoot strikers, whereas the female PFP group had 15 rearfoot strike runners. The chi- 389 
squared test was non-significant (X2 (2) = 1.95, P=0.378). 390 
4. Discussion 391 
Using a retrospective case-control approach, this study evaluated running biomechanics 392 
in patients with and without PFP via a musculoskeletal simulation-based approach, also 393 
investigated potential distinctions in PFP presentation between the sexes. This study rep- 394 
resents the first exploration of the biomechanical parameters linked to the aetiology of 395 
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PFP using musculoskeletal simulation, and may yield important clinical information to- 396 
wards the cessation of symptom initiation and the improvement in PFP management. 397 
Notably, patellofemoral stress indices were statistically greater in the PFP group 398 
compared to controls. This supports the notion that in runners, PFP is mediated by in- 399 
creased joint loading, and concurs with the findings of Brechter & Powers, [50], who found 400 
enhanced patellofemoral joint stress in those with PFP using a mixed sample. The subset 401 
analyses from this study importantly revealed that enhanced patellofemoral joint stress in 402 
PFP runners was driven by females, as no differences were evident in males. The female 403 
PFP group exhibited more pronounced and coherent differences in patellofemoral joint 404 
loading, importantly highlighting potential sex differences in PFP aetiology. This empha- 405 
sizes the need for different treatment approaches in male and female runners and man- 406 
agement strategies seeking to reduce patellofemoral joint stress are likely to be most effi- 407 
cacious in female runners. Patellofemoral joint loading is primarily actuated by forces 408 
generated within the quadriceps [51]. Therefore, enhanced patellofemoral joint stress in 409 
the female PFP group compared, was mediated as a function of the corresponding in- 410 
creases in forces which were observed consistently across all four quadriceps muscles. 411 
A significantly more anterior footstrike position was shown in the control group in 412 
relation to the PFP group, which when contextualized via the strike index, revealed a rear- 413 
foot strike in the PFP group and a midfoot pattern in controls. The subset analyses again 414 
showed that this was mediated by female runner’s and the chi-square analyses support 415 
this, as significantly more rearfoot strikers were shown in the overall and female PFP 416 
groups. Daoud et al., [52] showed that runners who habitually adopt a rearfoot strike pat- 417 
tern are more than twice as likely to experience a chronic running injury. Crucially, this 418 
investigation provides further precision to this observation, as in female runners the uti- 419 
lization of a rearfoot strike pattern makes runners significantly more likely to experience 420 
PFP. It is likely that the increased quadriceps muscle forces and patellofemoral loading 421 
shown overall and in the female PFP group, was mediated via the rearfoot strike pattern 422 
adopted in relation to control runners. Utilization of a rearfoot strike pattern places in- 423 
creased demands on the knee extensors [53], and patellofemoral stress is greater in rear- 424 
foot strikers [54]. From a clinical perspective, transitioning from a rearfoot strike pattern 425 
has been shown to attenuate patellofemoral joint loading and improve pain symptoms in 426 
male runners, although no such intervention has been undertaken in females [25]. There- 427 
fore, gait-retraining approaches which allow female PFP runners to modify their habitual 428 
footstrike pattern, may be a particularly important clinical intervention. 429 
From a kinematic and temporal perspective, peak knee flexion and step length were 430 
lower in the PFP group and knee flexion lower in male symptomatic runners compared 431 
to females with PFP. Individuals with PFP utilize reduced knee flexion [55, 56], which 432 
allied to the reductions in step length, may represent an attempt to minimize pain symp- 433 
toms by mediating patellofemoral stress [49, 55]. Reduced knee flexion in both the overall 434 
PFP and male PFP runners, may be indicative of kinesiophobia, a renowned complaint in 435 
patients with PFP [10, 56]. Kinesiophobia, is more severe in males with chronic musculo- 436 
skeletal pain [57, 58]. Therefore, as knee bracing [59] and exercise therapy [60] have been 437 
shown to improve kinesiophobia in PFP, this suggests there is scope for targeted inter- 438 
ventions towards male symptomatic runners. 439 
The overall and male and female subset comparisons showed that peak eversion was 440 
significantly greater in PFP runners. Rearfoot eversion has been linked to the aetiology of 441 
PFP by theoretical modelling analyses [61], and Dierks et al., [18] showed significantly 442 
larger eversion in PFP runners in a mixed sample, though this investigation is the first to 443 
show increased eversion in sex specific subset analyses. From a clinical standpoint, it ap- 444 
pears that strategies centred around reducing rearfoot eversion are important to the treat- 445 
ment of PFP in both male and female runners. Conservative modalities such as foot or- 446 
thoses and ankle braces have been shown to mediate statistical reductions in peak ankle 447 
eversion in both male and female runners [62, 63]. No analyses have been undertaken 448 
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using ankle bracing, however previous intervention studies have shown foot orthoses to 449 
be effective in treating PFP with greater rearfoot eversion angles at baseline predicting 450 
orthotic efficacy [64, 65].  451 
This investigation also revealed in the overall and male and female subset compari- 452 
sons, that contralateral pelvic drop ROM was significantly larger in PFP runners. This 453 
supports Bramah et al., [66] who showed that injured runners demonstrated greater con- 454 
tralateral pelvic drop and Willson & Davis, [19] who indicated that runners with PFP ex- 455 
hibited significantly greater contralateral pelvic drop. Enhanced contralateral pelvic drop 456 
negatively influences patellofemoral joint biomechanics by elongating the ipsilateral ili- 457 
otibial band, generating a greater laterally directed force on the patella [67, 68]. Increased 458 
contralateral pelvic drop during weightbearing activities and in PFP patients is consid- 459 
ered a clinical sign of diminished strength or neuromuscular function at the hip [66], 460 
which results in diminished capacity to stabilize the pelvis. This investigation supports 461 
this notion, as forces in the muscles primarily involved in stabilizing the pelvis were found 462 
to be statistically greater in the control group across all of the aforementioned group com- 463 
parisons. Importantly, real-time gait retraining has been shown to significantly attenuate 464 
contralateral pelvic drop and pain symptoms in runners with PFP and that hip strength- 465 
ening is able to mediate statistical improvements in PFP pain symptoms [69]. The findings 466 
from the current investigation importantly support the collective utilization of these in- 467 
tervention modalities in runners of both sexes. 468 
The overall as well as the male and female comparisons showed that % contributions 469 
of the rectus femoris were consistently greater in PFP runners, and that the same was true 470 
in symptomatic male runners. This suggests that over utilization of the rectus femoris is a 471 
potentially important biomechanical mechanism in PFP, and able to differentiate between 472 
sexes in symptomatic runners. Although, the mechanistic influence of this finding relating 473 
to the aetiology of PFP is not known, it is nonetheless a potentially clinically meaningful 474 
neuromuscular observation that may aid in the management of PFP in runners of both 475 
sexes. Furthermore, the overall and subgroup comparison of symptomatic runners 476 
showed an enhanced co-contraction ratio in control runners and symptomatic females. 477 
This observation opposes those of Besier et al., [23], showing no differences between PFP 478 
and healthy controls during running, although this investigation utilized electromyogra- 479 
phy rather than muscle forces. Nonetheless, it is proposed that these observations are me- 480 
diated as a function of the enhanced hamstring and reduced rectus femoris muscle forces 481 
that were evident in the above overall and subgroup comparisons. It remains unknown 482 
whether these alterations in muscle kinetics are adaptive in response to pain or if they are 483 
causative, but it can be speculated that increased co-contraction might enhance knee joint 484 
stability and benefit the position of the patella within the trochlear groove [70].  485 
In contrary to the observations of both Willy et al., [20] and Neal et al., [4] our find- 486 
ings showed that females with PFP did not exhibit a greater peak hip adduction angle 487 
compared to controls. However, in agreement with Willy et al., [20] our results show that 488 
female runners with PFP ran with statistically larger hip adduction in relation to sympto- 489 
matic males. Previous intervention trials show that targeted gait-retraining reduces peak 490 
hip adduction during running and improve pain and function in runners with PFP [71]. 491 
The observations from this investigation suggest that these interventions are likely to be 492 
most effective in females and the implementation of gait re-training to attenuate hip ad- 493 
duction in symptomatic female runners is encouraged. Taking into account the range of 494 
sex specific differences in running biomechanics between symptomatic runners, demon- 495 
strates sex specificity in terms of PFP presentation. Indicating that future clinical investi- 496 
gations whether, should present aetiological data for both sexes, and that treatment mo- 497 
dalities should also be correspondingly sex specific. 498 
Like any investigation, there are limitations to the current study, and the findings 499 
should be contextualized in line with these limitations. Firstly, the retrospective nature of 500 
the study design means that it is not possible to determine whether the biomechanical 501 
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differences between symptomatic runners and healthy controls are adaptations in the 502 
presence of anterior knee pain or if they are causative parameters. Owing to the expense 503 
and difficulty of undertaking analyses of this nature, there are a lack of prospective anal- 504 
yses identifying risk factors for PFP, so this is a clear avenue for future research. In addi- 505 
tion, PFP is a multifactorial condition; therefore, although the current investigation ex- 506 
plored a plethora of parameters using musculoskeletal simulation, it was beyond the 507 
scope of this study to determine the non-biomechanical risk factors that may be important 508 
to the aetiology of PFP. Future analyses should seek to investigate additional measure- 509 
ments that may be important to the aetiology and clinical management of PFP.  510 
5. Conclusions 511 
This investigation augments the existing literature in clinical biomechanics by providing 512 
a retrospective exploration of running biomechanics in runners with and without PFP us- 513 
ing musculoskeletal simulation. With overall PFP as well as female PFP runners exhibiting 514 
enhanced patellofemoral stress in addition to a significantly lower strike index, peak ever- 515 
sion and contralateral pelvic drop being greater in overall, male and female PFP runners, 516 
symptomatic females exhibiting a significantly larger peak hip adduction compared to 517 
PFP males and peak knee flexion being reduced in overall PFP and male PFP runners 518 
compared to symptomatic females; this investigation highlights potential risk factors for 519 
PFP that may be addressed through focused intervention modalities. Specifically, gait re- 520 
training approaches allowing female PFP runners to modify their habitual footstrike pat- 521 
tern and attenuate hip joint adduction, foot orthoses to reduce eversion and targeted gait 522 
re-training to reduce pelvic drop in male and female PFP runners and knee bracing and 523 
exercise therapy to mediate potential symptoms of kinesiophobia in male PFP runners, 524 
appear to represent particularly important clinical interventions. 525 
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Figure 1: a. Experimental marker locations and b. trunk, pelvis, thigh, shank and foot segments, with segment co-ordinate system 688 
axes (R = right & L = left), (TR = trunk, P = pelvis, T = thigh, S = shank & F = foot), (X = sagittal, Y = coronal & Z = transverse planes). 689 




Figure 2: Definitions of foot strike modalities according to the strike index [39]. a. Rear-foot strike; b. mid-foot strike & c. fore-foot 691 
strike. 692 
Appl. Sci. 2021, 11, x FOR PEER REVIEW 16 of 24 
 
 















Table 2: Three-dimensional kinematics in overall PFP participants and controls. 
  Control Patellofemoral 
      
  Mean SD Mean SD t b b (95% CI) p OR OR (95% CI) 
Sagittal plane 
Hip ROM (°) 0.60 1.12 1.78 1.93 3.39 1.21 0.50 - 1.92 0.001 1.75 1.18 - 2.59 
Knee angle at footstrike (°) 16.83 8.81 11.85 5.41 3.17 5.23 1.95 - 8.51 0.002 0.90 0.83 - 0.97 
Peak knee flexion (°) 43.95 6.71 40.29 7.80 2.08 3.41 0.15 - 6.68 0.041 0.93 0.873 - 1.00 
Coronal plane 
Pelvic ROM (°) 1.73 1.45 3.16 2.05 3.33 1.32 0.53 - 2.12 0.001 1.54 1.15 - 2.05 
Knee angle at footstrike (°) 0.50 5.23 -2.71 4.63 2.69 2.99 0.78 - 5.20 0.009 0.88 0.80 - 0.97 
Knee ROM (°) 6.31 4.06 3.83 2.58 3.14 2.41 0.88 - 3.94 0.002 0.81 0.70 - 0.94 
Ankle angle at footstrike (°) 5.66 5.04 -4.39 6.05 8.02 10.10 7.59 - 12.60 <0.001 0.70 0.60 - 0.82 
Peak ankle eversion (°) -8.15 4.19 -15.09 7.39 5.26 7.12 4.43 - 9.82 <0.001 0.78 0.70 - 0.88 
Transverse plane 
Hip angle at footstrike (°) 3.66 10.30 -1.45 9.50 2.08 4.64 0.20 - 9.07 0.041 0.95 0.91 - 1.01 
Knee angle at footstrike (°) -9.96 8.62 -4.61 7.75 2.66 4.90 1.23 - 8.56 0.009 1.08 1.01 - 1.15 
Knee ROM (°) 17.48 6.66 12.98 4.86 3.08 3.98 1.42 - 6.56 0.003 0.88 0.80 - 0.97 
 Control PFP Male control Male PFP Female control Female PFP 
 Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Age (yrs) 33.25 10.78 35.85 9.29 33.87 10.42 36.60 9.07 32.76 11.55 34.60 9.83 
Mass (kg) 70.91 9.65 73.01 15.19 75.65 9.81 80.00 14.59 65.21 8.31 64.02 10.34 
Stature (m) 1.73 0.09 1.73 0.08 1.74 0.07 1.77 0.07 1.68 0.10 1.66 0.04 
BMI (kg/m2) 24.55 3.26 24.46 3.36 23.79 3.00 25.39 3.44 23.22 3.66 23.20 2.83 
Speed (m/s) 3.89 0.43 3.66 0.58 3.90 0.52 3.72 0.60 3.86 0.27 3.56 0.55 
Step length (m) 1.47 0.36 1.20 0.23 1.50 0.29 1.21 0.23 1.43 0.45 1.19 0.24 
Mean weekly running volume (km) 27.12 15.51 30.09 19.62 29.04 19.14 30.94 19.72 25.21 10.96 29.24 19.99 
Symptom duration (Months) N/A 48.73 32.06 N/A 42.32 26.84 N/A 55.13 36.10 
KOOS-PF N/A 61.25 15.37 N/A 58.10 15.34 N/A 66.50 14.40 
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Ankle angle at footstrike (°) -6.38 7.90 -15.68 4.74 6.37 9.38 6.45 - 12.32 <0.001 0.80 0.721 - 0.89 




Table 3: Joint loading and temporal indices in overall PFP participants and controls. 
 
 
Table 4: Muscle force indices in overall PFP participants and controls. 
 Control Patellofemoral 
      
 Mean SD Mean SD t b b (95% CI) p OR OR (95% CI) 
Peak adductor longus force (BW) 0.74 0.38 0.54 0.27 2.57 0.19 0.04 - 0.34 0.012 0.17 0.04 - 0.74 
Peak extensor hallucis longus force (BW) 0.22 0.09 0.28 0.09 2.77 0.06 0.02 - 0.10 0.007 724.81 7.72 - 111369.08 
Flexor digitorum longus impulse (BW.ms) 10.03 5.46 7.03 2.88 2.77 2.70 0.76 - 4.64 0.007 0.83 0.71 - 0.968 
Flexor hallucis longus impulse (BW.ms) 10.76 6.95 7.57 3.55 2.56 3.20 0.72 - 5.69 0.012 0.86 0.76 - 0.99 
Gluteus minimus impulse (BW.ms) 130.34 35.28 115.47 24.33 2.75 18.22 5.02 - 31.42 0.007 0.98 0.96 - 1.00 
Peak lateral gastrocnemius force (BW) 0.86 0.24 0.96 0.19 2.13 0.10 0.01 - 0.20 0.036 11.22 1.10 - 114.35 
Peroneus tertius impulse (BW.ms) 8.22 3.30 5.84 2.62 3.07 1.96 0.69 - 3.24 0.003 0.77 0.64 - 0.94 
Rectus femoris impulse (BW.ms) 166.05 76.86 225.19 52.79 3.87 57.54 27.91 - 87.16 <0.001 1.01 1.01 - 1.02 
Peak semimembranosus force (BW) 0.52 0.13 0.65 0.20 3.06 0.11 0.04 - 0.18 0.003 90.44 3.75 - 2184.09 
Semitendinosus impulse (BW.ms) 21.01 7.18 12.30 8.53 4.81 8.56 5.02 - 12.11 <0.001 0.88 0.82 - 0.94 
Peak semitendinosus force (BW) 0.31 0.07 0.24 0.12 3.00 0.07 0.02 - 0.11 0.004 0.01 0.00 - 0.14 
 Control Patellofemoral       
 Mean SD Mean SD t b b (95% CI) p OR OR (95% CI) 
Strike index (%) 33.57 22.09 17.75 16.43 3.52 15.47 6.71 - 24.22 0.001 0.946 0.91 - 0.98 
Step length (m) 1.47 0.36 1.20 0.23 3.65 0.24 0.11 - 0.38 <0.001 0.043 0.01 - 0.33 
Patellofemoral force per mile (BW) 440.24 204.84 550.33 192.08 2.14 94.46 6.55 - 182.37 0.036 1.003 1.00 - 1.01 
Patellofemoral stress per mile (KPa/ BW) 812.93 363.66 1047.49 333.02 2.64 203.77 50.07 - 357.47 0.01 1.002 1.001 - 1.004 
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Soleus impulse (BW.ms) 467.68 118.87 396.30 80.47 3.33 76.05 30.62 - 121.48 0.001 0.99 0.99 - 1.00 
Biceps femoris short head (%) 30.62 8.92 34.42 11.11 2.10 4.69 0.24 - 9.13 0.039 1.055 1.00 - 1.11 
Semitendinosus (%) 15.68 4.60 9.51 4.62 5.70 5.89 3.83 - 7.94 <0.001 0.768 0.68 - 0.87 
Rectus femoris (%) 19.49 4.97 25.97 7.25 4.64 6.52 3.72 - 9.31 <0.001 1.260 1.11 - 1.43 
Vastus intermedius (%) 23.38 1.36 21.50 2.02 4.84 1.88 1.11 - 2.66 <0.001 0.405 0.25 - 0.65 
Vastus lateralis (%) 35.95 2.78 33.20 3.53 3.88 2.79 1.36 - 4.21 <0.001 0.721 0.59 - 0.88 
Vastus medialis (%) 21.17 1.35 19.33 1.83 5.07 1.85 1.12 - 2.57 <0.001 0.36 0.22 - 0.61 
















Table 6: Muscle force indices in male PFP participants and controls. 
 
 Male control Male PFP       
 
 Mean SD Mean SD t b b (95% CI) p OR OR (95% CI) 
Coronal plane 
Pelvic ROM (°) 1.62 1.40 2.88 1.99 2.34 0.57 0.08 - 1.06 0.023 1.51 1.03 - 2.20 
Ankle angle at footstrike (°) 5.35 4.72 -4.06 5.21 6.85 4.83 3.41 - 6.25 p<0.001 0.67 0.54 - 0.83 
Peak ankle eversion (°) -8.05 3.48 -14.69 6.13 5.07 3.53 2.13 - 4.93 p<0.001 0.68 0.54 - 0.86 
Transverse 
plane 
Ankle angle at footstrike (°) -8.77 8.15 -15.33 5.49 3.40 3.35 1.37 - 5.33 0.001 0.86 0.78 - 0.96 
Ankle ROM (°) 7.24 3.91 0.69 1.12 8.02 3.24 2.43 - 4.04 p<0.001 0.37 0.22 - 0.64 
 Male control Male PFP       
 Mean SD Mean SD t b b (95% CI) p OR OR (95% CI) 
Adductor magnus impulse (BW.ms) 53.33 30.55 36.75 19.79 2.61 9.27 2.13 - 16.41 0.012 0.97 0.94 - 1.00 
Gluteus minimus impulse (BW.ms) 126.55 38.37 108.45 24.42 2.32 10.28 1.37 - 19.19 0.025 0.98 0.96 - 1.01 
Peroneus brevis impulse (BW.ms) 51.55 24.23 37.05 23.70 2.33 7.88 1.07 - 14.69 0.024 0.97 0.95 - 0.99 
Peak peroneus brevis force (BW) 0.60 0.21 0.46 0.22 2.27 0.07 0.01 - 0.13 0.028 0.04 0.004 - 0.85 
















Semitendinosus impulse (BW.ms) 20.27 7.44 9.98 7.95 4.66 5.15 0.293 - 7.38 <0.001 0.85 0.77 - 0.93 
Peak semitendinosus force (BW) 0.30 0.08 0.20 0.11 3.67 0.05 0.02 - 0.08 0.001 0.003 0.001 - 0.03 
Soleus impulse (BW.ms) 464.90 135.71 383.28 73.12 2.74 42.16 11.22 - 73.10 0.009 0.99 0.98 - 1.00 
Semitendinosus (%) 15.53 4.18 8.87 4.77 5.06 3.24 1.95 - 4.52 <0.001 0.74 0.63 - 0.88 
Rectus femoris (%) 21.30 3.80 28.08 7.69 3.75 3.28 1.52 - 5.04 <0.001 1.321 1.10 - 1.59 
Vastus intermedius (%) 23.04 1.13 20.98 2.18 4.01 1.01 0.50 - 1.51 <0.001 0.330 0.16 - 0.67 
Vastus lateralis (%) 34.72 2.08 32.02 3.58 3.07 1.29 0.45 - 2.14 0.004 0.678 0.51 - 0.91 
Vastus medialis (%) 20.94 1.07 18.92 2.04 4.18 0.99 0.51 - 1.46 <0.001 0.283 0.13 - 0.63 
 
 Female control Female PFP       
   Mean SD Mean SD t b b (95% CI) p OR OR (95% CI) 
Sagittal plane 
Ankle angle at footstrike (°) 3.36 10.78 10.36 4.67 2.05 3.15 0.02 - 6.29 0.049 1.18 1.00 - 1.38 
Peak dorsiflexion (°) 16.51 4.29 20.19 3.12 2.73 1.88 0.05 - 3.29 0.01 1.35 1.04 - 1.74 
Coronal plane 
Pelvic ROM (°) 1.88 1.54 3.64 2.13 2.68 0.90 0.21 - 1.59 0.011 1.64 1.04 - 2.58 
Knee angle at footstrike (°) 1.16 5.38 -4.62 3.82 3.30 2.84 1.09 - 4.59 0.002 0.76 0.61 - 0.94 
Ankle angle at footstrike (°) 6.09 5.55 -4.93 7.41 4.39 5.10 2.73 - 7.47 P<0.001 0.75 0.60 - 0.93 
Peak ankle eversion (°) -8.28 5.11 -15.75 9.32 2.49 3.30 0.60 - 6.00 0.018 0.86 0.75 - 0.99 
Transverse 
plane 
Knee angle at footstrike (°) -12.32 7.83 -1.95 7.06 3.64 4.95 2.18 - 7.72 0.001 1.22 1.04 - 1.42 
Knee ROM (°) 17.88 5.82 10.39 3.88 3.76 3.34 1.58 - 5.15 0.001 0.75 0.60 - 0.94 
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Table 8: Joint loading and temporal indices in female PFP participants and controls. 
 
 
Table 9: Muscle force indices in female PFP participants and controls. 
 Female control Female PFP       
 Mean SD Mean SD t b b (95% CI) p OR OR (95% CI) 
Peak adductor longus force (BW) 0.75 0.41 0.51 0.24 2.07 0.13 0.06 - 0.16 0.043 0.21 0.01 – 0.97 
Peak biceps femoris force (BW) 0.80 0.23 1.01 0.28 2.52 0.12 0.02 - 0.21 0.017 55.52 1.47 - 2091.52 
Peak extensor hallucis longus force (BW) 0.17 0.06 0.27 0.12 2.89 0.05 0.01 - 0.09 0.007 215238 4.57 - 10134951829.16 
Peak lateral gastrocnemius force (BW) 0.81 0.24 1.02 0.18 2.59 0.10 0.02 - 0.18 0.014 199.27 2.16 - 18373.01 
Peak medial gastrocnemius force (BW) 1.79 0.24 2.12 0.33 3.38 0.17 0.07 - 0.28 0.002 305.1 2.72 - 34221.81 
Peak peroneus longus force (BW) 0.95 0.25 1.29 0.37 3.34 0.19 0.07 - 0.30 0.002 49.52 2.37 - 1035.09 
Psoas major impulse (BW.ms) 83.49 35.93 125.46 45.12 3.07 22.54 7.60 - 37.48 0.004 1.03 1.00 - 1.06 
Rectus femoris impulse (BW.ms) 117.08 49.13 199.54 49.23 4.69 41.97 23.72 - 60.21 p<0.001 1.04 1.01 - 1.07 
Peak semimembranosus force (BW) 0.52 0.15 0.75 0.19 3.36 0.09 0.04 - 0.15 0.002 2323.7 5.15 - 1047595.46 
Total quadriceps force impulse (BW.ms) 675.62 171.35 891.41 117.88 3.78 101.72 46.84 - 156.60 0.001 1.01 1.00 - 1.02 
Peak total quadriceps force (BW) 5.88 1.52 7.18 1.05 2.68 0.64 0.15 - 1.14 0.012 2.05 1.07 - 3.92 
Vastus intermedius impulse (BW.ms) 160.63 40.36 199.77 29.64 2.75 17.73 4.59 - 30.86 0.01 1.03 1.00 - 1.05 
  Female control Female PFP       
  Mean SD Mean SD t b b (95% CI) p OR OR (95% CI) 
Patellofemoral impulse (BW.ms) 655.07 192.48 817.74 125.04 2.51 74.88 14.18 - 135.59 0.017 1.01 1.00 - 1.02 
Peak patellofemoral force (BW) 6.13 1.79 7.31 1.08 2.13 0.58 0.02 - 1.14 0.041 1.73 1.01 - 2.98 
Peak patellofemoral stress (KPa/BW) 10.82 2.86 13.07 1.71 2.54 1.11 0.22 - 2.00 0.016 1.53 1.06 - 2.21 
Patellofemoral stress loading rate (KPa/BW/s) 318.53 124.27 402.55 129.66 2.52 55.48 10.60 - 100.36 0.017 1.01 1.00 - 1.02 
Patellofemoral stress impulse (KPa/BW.ms) 1205.92 314.27 1567.44 192.80 3.50 167.22 70.00 - 264.45 0.001 1.00 1.00 - 1.02 
Patellofemoral stress per mile (BW) 764.95 429.71 1116.67 361.68 2.64 203.77 50.07 - 357.46 0.01 1.01 1.00 - 1.02 
Vertical GRF impulse (BW.ms) 309.02 34.06 354.18 37.04 3.17 20.13 7.21 - 33.06 0.003 1.04 1.01 - 1.07 
Strike index (%) 40.20 21.69 15.49 3.37 3.94 11.29 5.45 - 17.13 p<0.001 0.79 0.65 - 0.95 
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Peak vastus intermedius impulse (BW.ms) 1.64 0.48 2.02 0.32 2.52 0.19 0.04 - 0.34 0.017 9.05 1.16 - 70.48 
Vastus medialis impulse (BW.ms) 145.29 38.61 178.72 27.68 2.48 15.24 2.73 - 27.75 0.019 1.03 1.00 - 1.06 
Peak vastus medialis force (BW) 1.50 0.45 1.83 0.31 2.32 0.17 0.02 - 0.31 0.027 8.48 1.02 - 70.87 
Semitendinosus (%) 15.88 5.23 10.59 4.30 2.67 2.29 0.54 - 4.05 0.012 0.80 0.63 - 0.98 
Rectus femoris (%) 17.06 5.42 22.46 4.88 3.21 2.99 1.09 - 4.89 0.003 1.27 1.05 - 1.54 
Vastus intermedius (%) 23.84 1.53 22.38 1.39 2.99 0.79 0.25 - 1.33 0.005 0.45 0.23 - 0.88 
Vastus lateralis (%) 37.62 2.79 35.17 2.46 3.00 1.41 0.45 - 2.38 0.005 0.66 0.47 - 0.93 
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  Male PFP Female PFP 
    
  Mean SD Mean SD t b b (95% CI) p 
Sagittal plane 
Hip angle at footstrike (°) 31.30 8.46 39.54 7.02 3.55 8.79 3.79 - 13.79 0.001 
Knee angle at footstrike (°) 10.15 4.69 14.69 5.49 2.89 4.62 1.38 - 7.86 0.006 
Peak knee flexion (°) 38.32 8.51 43.59 5.17 2.54 5.83 1.19 - 10.48 0.015 
Coronal plane Peak hip adduction (°) 7.62 5.73 11.30 2.71 2.38 3.71 0.57 - 6.85 0.02 
Transverse plane Knee ROM (°) 14.53 4.80 10.39 3.88 2.75 3.80 1.00 - 6.59 0.009 
 Male PFP Female PFP 
    
 Mean SD Mean SD t b b (95% CI) p 
Loading rate (BW/s) 150.08 45.89 173.28 39.12 2.18 27.91 1.97 - 53.85 0.036 





Table 12: Muscle force indices in male and female PFP participants. 
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 Male PFP Female PFP 
    
 Mean SD Mean SD t b b (95% CI) p 
Biceps femoris long head (BW.ms) 21.13 11.36 31.88 16.29 2.55 10.96 2.28 - 19.64 0.015 
Peak biceps femoris short head force (BW) 0.81 0.31 1.01 0.28 2.45 0.22 0.04 - 0.41 0.019 
Flexor digitorum longus impulse (BW.ms) 47.30 24.94 28.09 12.48 2.69 17.73 4.41 - 31.04 0.01 
Flexor hallucis longus impulse (BW.ms) 6.40 2.78 8.06 2.82 2.29 1.93 0.23 - 3.63 0.027 
Peak gluteus maximus force (BW) 142.04 48.48 178.45 45.06 2.47 37.41 6.82 - 67.99 0.018 
Gluteus maximus impulse (BW.ms) 1.40 0.45 1.69 0.42 2.81 0.35 0.10 - 0.60 0.008 
Gluteus medius impulse (BW.ms) 261.79 58.62 320.89 48.67 3.24 54.01 20.31 - 87.72 0.002 
Peak gluteus medius force (BW) 2.25 0.45 2.66 0.46 2.76 0.39 0.11 - 0.68 0.009 
Gluteus minimus impulse (BW.ms) 108.45 24.42 127.16 19.81 2.43 17.46 2.94 - 31.98 0.02 
Peak gluteus minimus force (BW) 0.95 0.21 1.16 0.22 3.00 0.20 0.07 - 0.34 0.005 
Peak gracillis force (BW) 0.08 0.05 0.11 0.04 2.93 0.04 0.01 - 0.06 0.006 
Peak iliacus force (BW) 2.01 0.39 2.40 0.37 3.48 0.42 0.17 - 0.66 0.0012 
Rectus femoris impulse (BW.ms) 240.58 49.58 199.54 49.23 2.55 40.50 8.42 - 72.58 0.015 
Peak sartorius force (BW) 0.24 0.05 0.30 0.05 3.76 0.06 0.03 - 0.09 0.001 
Peak semimembranosus impulse (BW.ms) 36.65 15.54 55.55 19.95 3.30 17.59 6.80 - 28.38 0.002 
Peak semimembranosus force (BW) 0.58 0.17 0.75 0.19 2.91 0.16 0.05 - 0.27 0.0059 
Semitendinosus impulse (BW.ms) 9.98 7.95 16.17 8.28 2.54 6.51 1.32 - 11.70 0.015 
Peak semitendinosus force (BW) 0.20 0.11 0.30 0.13 2.96 0.11 0.03 - 0.18 0.005 
Tensor fasciae latae impulse (BW.ms) 55.82 10.98 66.03 9.17 3.04 10.08 3.37 - 16.80 0.004 
Peak tensor fasciae latae force (BW) 0.45 0.08 0.57 0.07 4.98 0.12 0.07 - 0.16 p<0.001 
Tibialis impulse (BW.ms) 25.39 14.36 34.54 11.76 2.94 10.99 3.44 - 18.55 0.005 
Total hamstring impulse (BW.ms) 108.48 36.77 147.66 45.69 3.02 39.05 12.90 - 65.21 0.004 
Peak total hamstring force (BW) 1.39 0.47 1.66 0.46 2.01 0.29 0.06 - 0.59 0.048 
Rectus femoris (%) 28.08 7.69 22.46 4.88 2.67 5.79 1.40 - 10.18 0.011 
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 Vastus intermedius (%) 20.98 2.18 22.38 1.39 2.38 1.46 0.22 - 2.70 0.022 
Vastus lateralis (%) 32.02 3.58 35.17 2.46 3.10 3.20 1.11 - 5.28 0.004 
Mean co-contraction ratio 0.13 0.07 0.19 0.06 2.34 0.05 0.006 - 0.09 0.024 
Peak co-contraction ratio 0.19 0.08 0.25 0.09 2.12 0.06 0.003 - 0.12 0.04 
